Chlorproguanil/dapsone/artesunate
Chlorproguanil/dapsone/artesunate (also known as CDA) is a fixed-dose combination medication used in the treatment of malaria. It contains three active ingredients: chlorproguanil, dapsone, and artesunate.
Composition[edit | edit source]
The medication is composed of three active ingredients. Chlorproguanil is a biguanide antimalarial drug. It works by inhibiting the dihydrofolate reductase enzyme, which is necessary for the synthesis of DNA in the malaria parasite. Dapsone is an antibiotic that has antimalarial properties. It also inhibits the synthesis of dihydrofolic acid, but in a different way than chlorproguanil. Artesunate is a derivative of artemisinin, a compound found in the sweet wormwood plant. It is a fast-acting antimalarial drug that kills malaria parasites by producing free radicals in their cells.
Indications[edit | edit source]
CDA is used for the treatment of uncomplicated Plasmodium falciparum malaria. It is particularly useful in areas where the malaria parasite has developed resistance to other antimalarial drugs.
Dosage and Administration[edit | edit source]
The dosage of CDA depends on the patient's body weight. It is usually taken once a day for three days. The medication should be taken with food to enhance absorption.
Side Effects[edit | edit source]
Common side effects of CDA include nausea, vomiting, and abdominal pain. Less common side effects include anemia, neutropenia, and methemoglobinemia. Rare but serious side effects include severe skin reactions and liver problems.
Contraindications[edit | edit source]
CDA is contraindicated in patients with known hypersensitivity to any of the active ingredients. It is also contraindicated in patients with severe renal impairment, severe hepatic impairment, or glucose-6-phosphate dehydrogenase deficiency.
Interactions[edit | edit source]
CDA can interact with other medications, including other antimalarial drugs, antiretroviral drugs, and certain antibiotics. It is important to inform the healthcare provider of all medications being taken before starting treatment with CDA.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD